Cubic Pharmaceuticals (003020.SZ) released its first half-year performance report, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53%.

Wisdom Finance APP News, Lufax Pharmaceutical (003020.SZ) released its 2025 interim report. The company's operating income was 732 million yuan, a decrease of 4.80% year-on-year. Net profit attributable to shareholders of the listed company was 90.2271 million yuan, an increase of 16.53% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.2209 million yuan, a decrease of 9.68% year-on-year. Basic earnings per share were 0.47 yuan.